1. Home
  2. CRVL vs IRON Comparison

CRVL vs IRON Comparison

Compare CRVL & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CorVel Corp.

CRVL

CorVel Corp.

HOLD

Current Price

$56.37

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.44

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVL
IRON
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CRVL
IRON
Price
$56.37
$69.44
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$103.18
AVG Volume (30 Days)
187.9K
346.7K
Earning Date
05-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.53
N/A
Revenue
$895,589,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$283.52
P/E Ratio
$36.54
N/A
Revenue Growth
12.61
N/A
52 Week Low
$44.83
$40.00
52 Week High
$117.22
$99.50

Technical Indicators

Market Signals
Indicator
CRVL
IRON
Relative Strength Index (RSI) 59.34 60.63
Support Level $51.10 $57.79
Resistance Level $71.89 $69.36
Average True Range (ATR) 2.04 2.64
MACD 0.29 0.94
Stochastic Oscillator 87.29 87.19

Price Performance

Historical Comparison
CRVL
IRON

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: